Moderna says its COVID-19 vaccine generates immune response in young children

Well-tolerated in children aged six to 11 years

  
A vial of the Moderna coronavirus disease (COVID-19) vaccine is pictured at a care home in Naples, Italy, March 30, 2021.

A vial of the Moderna coronavirus disease (COVID-19) vaccine is pictured at a care home in Naples, Italy, March 30, 2021.

REUTERS/Ciro De Luca

Moderna Inc said on Monday that its COVID-19 vaccine generated an immune response and was generally well-tolerated in children aged six to 11 years, citing interim data from a study.

(Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta) ((Manas.Mishra@thomsonreuters.com; www.twitter.com/Manasmishra24; within U.S. +1 646 223 8780, outside U.S. +91 806749 2709))


More From Health